Aviragen Therapeutics (AVIR) Tops Q1 EPS by 1c
Get Alerts AVIR Hot Sheet
Join SI Premium – FREE
Aviragen Therapeutics (NASDAQ: AVIR) reported Q1 EPS of ($0.40), $0.01 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cinema United: issues joint letter to state AGs and Paramount
- Bill Rasmussen, ESPN founder, dies at 93
- Amylyx Pharmaceuticals (AMLX) 19K contracts trade
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share